Ion Beam Applications, SA

IBAB

BE0003766806

Advanced Medical Equipment & Technology

Market Closed - Euronext Bruxelles Other stock markets 11:35:06 2025-02-07 am EST			5-day change	1st Jan Change
13.48 ^EUR	+2.74%		+0.60%	+0.45%

Feb. 07	Ion Beam Applications, Framatome Partner to Produce Cancer Therapy Radioisotope	MT
Feb. 07	Framatome, IBA To Partner To Develop An Astatine-211 Cyclotron Network	RE

Ion Beam Applications SA(ENXTBR:IBAB) added to S&P Global BMI Index

September 22, 2024

Latest news about Ion Beam Applications, SA

Ion Beam Applications, Framatome Partner to Produce Cancer Therapy Radioisotope	Feb. 07	MT
Framatome, IBA To Partner To Develop An Astatine-211 Cyclotron Network	Feb. 07	RE
Framatome and IBA to Partner to Develop an Astatine-211 Cyclotron Network in Europe and the USA	Feb. 07	CI
IBA Signs Proteus One System Contract With AIG In India	Feb. 06	RE
Ion Beam Applications S.A. Signs Proteus®?One System Contract with Asian Institute of Gastroenterology	Feb. 06	CI
IBA, Wallonie Entreprendre Invest in German Startup	Jan. 21	MT
Mi2-factory GmbH announced that it has received funding from WALLONIE Entreprendre, Ion Beam Applications SA	Jan. 20	CI
Ion Beam Applications CFO to Step Down on end-January	Jan. 17	MT
Iba Announces Stepping Down of Soumya Chandramouli as Chief Financial Officer, Effective 31 January 2025	Jan. 17	CI
Ion Beam Applications Secures Deal to Equip Sterilization Tech in Dominican Republic	Nov. 06	MT
SteriLab Selects Ion Beam Applications to Equip its New Facility at Haina Port in the Dominican Republic with E-beam Sterilization Solution	Nov. 06	CI
Ion Beam Applications SA(ENXTBR:IBAB) added to S&P Global BMI Index	24-09-22	CI
EQT Life Sciences-led Oversubscribed Funding Round Raises EUR134 Million	24-09-11	MT
EQT Leads $102.5 Million Series A Funding Round in Belgian Radioisotope Producer PanTera	24-09-11	DJ
Ion Beam Applications SA Reports Earnings Results for the Half Year Ended June 30, 2024	24-08-29	CI
Ion Beam Applications SA, H1 2024 Earnings Call, Aug 29, 2024	24-08-29
Ion Beam Applications Signs MoU to Install Proton Therapy Systems in US	24-08-27	MT
Ion Beam Applications S.A. Secures Deal with the University of Pennsylvania Health System for Two Proteus®ONE Proton Therapy Solutions	24-08-27	CI
Ion Beam Applications SA Signs Contract with Yale New Haven Health and Hartford HealthCare to Install Proteus®?One Proton Therapy Solution in Connecticut, US	24-05-02	CI
Ion Beam Applications SA completed the acquisition of all the assets of Radcal Corporation.	24-03-30	CI
Ion Beam Applications SA, 2023 Earnings Call, Mar 21, 2024	24-03-21
Ion Beam Applications SA Reports Earnings Results for the Full Year Ended December 30, 2023	24-03-21	CI
Ion Beam Applications Books Order for Electron Beam Irradiation System	24-03-19	MT
Ion Signs Contract to Install Be-Efficient Irradiation Solution in Germany	24-03-19	CI
Ion Beam Applications Bags Cyclotron Order	24-02-29	MT

Chart Ion Beam Applications, SA

Duration

Period

IBAB: Dynamic Chart

Ion Beam Applications, SA (IBA) specializes in the design, manufacture, and marketing of cancer treatment and diagnosis equipment. Net sales break down by family of products as follows: - diagnosis and therapeutic treatment equipment and systems (84.8%): proton therapy equipment (62.5% of net sales; No. 1 worldwide), and particle accelerators (36.5%) used in the production of radioisotopes (cyclotrons) and in the development of sterilization and ionization solutions (Rhodotron® and Dynamitron®); - equipment and solutions of dosimetry (15.2%; No. 1 worldwide): measurement and analysis tools of the radiation doses in medical imaging and radiation therapy. Net sales are distributed geographically as follows: the United States (31.7%) and other (68.3%).

Employees

1,943

Sector

Advanced Medical Equipment & Technology

Calendar

2025-03-20 - Q4 2024 Earnings Release

More about the company